Comparison of Diagnostic Sensitivity and Quantitative Indices Between 68Ga-DOTATOC PET/CT and 111In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-08-26

AUTHORS

Inki Lee, Jin Chul Paeng, Soo Jin Lee, Chan Soo Shin, Jin-Young Jang, Gi Jeong Cheon, Dong Soo Lee, June-Key Chung, Keon Wook Kang

ABSTRACT

PurposeIn-pentetreotide has been used for neuroendocrine tumors expressing somatostatin receptors. Recently, 68Ga-DOTATOC PET has been used with the advantage of high image quality. In this study, we compared quantitative indices between 111In-pentetreotide SPECT/CT and 68Ga-DOTATOC PET/CT.MethodsThirteen patients diagnosed with neuroendocrine tumors were prospectively recruited. Patients underwent 111In-pentetreotide scans with SPECT/CT and 68Ga-DOTATOC PET/CT before treatment. The number and location of lesions were analyzed on both imaging techniques to compare lesion detectability. Additionally, the maximal uptake count of each lesion and mean uptake count of the lungs were measured on both imagings, and target-to-normal lung ratios (TNR) were calculated as quantitative indices.ResultsAmong 13 patients, 10 exhibited lesions with increased uptake on 111In-pentetreotide SPECT/CT and/or 68Ga-DOTATOC PET/CT. Scans with SPECT/CT detected 19 lesions, all of which were also detected on PET/CT. Moreover, 16 additional lesions were detected on PET/CT (6 in the liver, 9 in the pancreas and 1 in the spleen). PET/CT exhibited a significantly higher sensitivity than SPECT/CT (100 % vs. 54 %, P < 0.001). TNR was significantly higher on PET/CT than on SPECT/CT (99.9 ± 84.3 vs. 71.1 ± 114.9, P < 0.001) in spite of a significant correlation (r = 0.692, P = 0.01).ConclusionGa-DOTATOC PET/CT has a higher diagnostic sensitivity than 111In-pentetreotide scans with SPECT/CT. The TNR on PET/CT is higher than that of SPECT/CT, which also suggests the higher sensitivity of PET/CT. 111In-pentetreotide SPECT/CT should be used carefully if it is used instead of 68Ga-DOTATOC PET/CT. More... »

PAGES

284-290

References to SciGraph publications

  • 2000-03. Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-10-16. SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors in MOLECULAR IMAGING AND BIOLOGY
  • 2011-09-17. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2003-10. Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemoradiotherapy in ANNALS OF NUCLEAR MEDICINE
  • 2007-05-23. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2013-12-18. Diagnostic Value of 68Ga-DOTATATE PET/CT in Liver Metastases of Neuroendocrine Tumours of Unknown Origin in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-09-02. Lesion-based analysis of 18F-FDG uptake and 111In-Pentetreotide uptake by neuroendocrine tumors in ANNALS OF NUCLEAR MEDICINE
  • 2012-02-20. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis in ENDOCRINE
  • 2012-06-29. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings in ABDOMINAL RADIOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-015-0356-y

    DOI

    http://dx.doi.org/10.1007/s13139-015-0356-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1034059814

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/26550047


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Inki", 
            "id": "sg:person.01216340016.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216340016.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paeng", 
            "givenName": "Jin Chul", 
            "id": "sg:person.01343511335.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511335.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Soo Jin", 
            "id": "sg:person.01226703142.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226703142.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shin", 
            "givenName": "Chan Soo", 
            "id": "sg:person.0706114440.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706114440.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Seoul National University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Surgery, Seoul National University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jang", 
            "givenName": "Jin-Young", 
            "id": "sg:person.0617241524.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617241524.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research Institute, Seoul National University, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
                "Cancer Research Institute, Seoul National University, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cheon", 
            "givenName": "Gi Jeong", 
            "id": "sg:person.01333472502.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Gyeonggi-Do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
                "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Gyeonggi-Do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Dong Soo", 
            "id": "sg:person.015617314175.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research Institute, Seoul National University, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
                "Cancer Research Institute, Seoul National University, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chung", 
            "givenName": "June-Key", 
            "id": "sg:person.0751347234.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research Institute, Seoul National University, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea", 
                "Cancer Research Institute, Seoul National University, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kang", 
            "givenName": "Keon Wook", 
            "id": "sg:person.0761746266.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s002590050034", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036382831", 
              "https://doi.org/10.1007/s002590050034"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12020-012-9631-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017361379", 
              "https://doi.org/10.1007/s12020-012-9631-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11307-014-0795-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029679413", 
              "https://doi.org/10.1007/s11307-014-0795-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-011-1935-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006918703", 
              "https://doi.org/10.1007/s00259-011-1935-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00261-012-9925-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018718191", 
              "https://doi.org/10.1007/s00261-012-9925-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-007-0450-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004095362", 
              "https://doi.org/10.1007/s00259-007-0450-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13139-013-0258-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000221223", 
              "https://doi.org/10.1007/s13139-013-0258-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03006672", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003746639", 
              "https://doi.org/10.1007/bf03006672"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-014-0900-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043318385", 
              "https://doi.org/10.1007/s12149-014-0900-3"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-08-26", 
        "datePublishedReg": "2015-08-26", 
        "description": "PurposeIn-pentetreotide has been used for neuroendocrine tumors expressing somatostatin receptors. Recently, 68Ga-DOTATOC PET has been used with the advantage of high image quality. In this study, we compared quantitative indices between 111In-pentetreotide SPECT/CT and 68Ga-DOTATOC PET/CT.MethodsThirteen patients diagnosed with neuroendocrine tumors were prospectively recruited. Patients underwent 111In-pentetreotide scans with SPECT/CT and 68Ga-DOTATOC PET/CT before treatment. The number and location of lesions were analyzed on both imaging techniques to compare lesion detectability. Additionally, the maximal uptake count of each lesion and mean uptake count of the lungs were measured on both imagings, and target-to-normal lung ratios (TNR) were calculated as quantitative indices.ResultsAmong 13 patients, 10 exhibited lesions with increased uptake on 111In-pentetreotide SPECT/CT and/or 68Ga-DOTATOC PET/CT. Scans with SPECT/CT detected 19 lesions, all of which were also detected on PET/CT. Moreover, 16 additional lesions were detected on PET/CT (6 in the liver, 9 in the pancreas and 1 in the spleen). PET/CT exhibited a significantly higher sensitivity than SPECT/CT (100\u00a0% vs. 54\u00a0%, P\u2009<\u20090.001). TNR was significantly higher on PET/CT than on SPECT/CT (99.9\u2009\u00b1\u200984.3 vs. 71.1\u2009\u00b1\u2009114.9, P\u2009<\u20090.001) in spite of a significant correlation (r\u2009=\u20090.692, P\u2009=\u20090.01).ConclusionGa-DOTATOC PET/CT has a higher diagnostic sensitivity than 111In-pentetreotide scans with SPECT/CT. The TNR on PET/CT is higher than that of SPECT/CT, which also suggests the higher sensitivity of PET/CT. 111In-pentetreotide SPECT/CT should be used carefully if it is used instead of 68Ga-DOTATOC PET/CT.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s13139-015-0356-y", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "49"
          }
        ], 
        "keywords": [
          "PET/CT", 
          "SPECT/CT", 
          "neuroendocrine tumors", 
          "uptake counts", 
          "diagnostic sensitivity", 
          "normal lung ratios", 
          "location of lesions", 
          "high diagnostic sensitivity", 
          "MethodsThirteen patients", 
          "lung ratio", 
          "additional lesions", 
          "somatostatin receptors", 
          "lesions", 
          "patients", 
          "CT", 
          "tumors", 
          "preliminary report", 
          "significant correlation", 
          "scans", 
          "quantitative index", 
          "lesion detectability", 
          "count", 
          "index", 
          "lung", 
          "high sensitivity", 
          "receptors", 
          "sensitivity", 
          "treatment", 
          "report", 
          "imaging", 
          "PET", 
          "uptake", 
          "target", 
          "image quality", 
          "TNR", 
          "study", 
          "correlation", 
          "high image quality", 
          "spite", 
          "quality", 
          "number", 
          "ratio", 
          "comparison", 
          "location", 
          "detectability", 
          "technique", 
          "advantages"
        ], 
        "name": "Comparison of Diagnostic Sensitivity and Quantitative Indices Between 68Ga-DOTATOC PET/CT and 111In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report", 
        "pagination": "284-290", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1034059814"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-015-0356-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "26550047"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-015-0356-y", 
          "https://app.dimensions.ai/details/publication/pub.1034059814"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:40", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_673.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s13139-015-0356-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-015-0356-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-015-0356-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-015-0356-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-015-0356-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    208 TRIPLES      21 PREDICATES      81 URIs      64 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-015-0356-y schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author Na018014cb4e34cd39d255cff55323718
    4 schema:citation sg:pub.10.1007/bf03006672
    5 sg:pub.10.1007/s00259-007-0450-1
    6 sg:pub.10.1007/s00259-011-1935-5
    7 sg:pub.10.1007/s002590050034
    8 sg:pub.10.1007/s00261-012-9925-z
    9 sg:pub.10.1007/s11307-014-0795-3
    10 sg:pub.10.1007/s12020-012-9631-1
    11 sg:pub.10.1007/s12149-014-0900-3
    12 sg:pub.10.1007/s13139-013-0258-9
    13 schema:datePublished 2015-08-26
    14 schema:datePublishedReg 2015-08-26
    15 schema:description PurposeIn-pentetreotide has been used for neuroendocrine tumors expressing somatostatin receptors. Recently, 68Ga-DOTATOC PET has been used with the advantage of high image quality. In this study, we compared quantitative indices between 111In-pentetreotide SPECT/CT and 68Ga-DOTATOC PET/CT.MethodsThirteen patients diagnosed with neuroendocrine tumors were prospectively recruited. Patients underwent 111In-pentetreotide scans with SPECT/CT and 68Ga-DOTATOC PET/CT before treatment. The number and location of lesions were analyzed on both imaging techniques to compare lesion detectability. Additionally, the maximal uptake count of each lesion and mean uptake count of the lungs were measured on both imagings, and target-to-normal lung ratios (TNR) were calculated as quantitative indices.ResultsAmong 13 patients, 10 exhibited lesions with increased uptake on 111In-pentetreotide SPECT/CT and/or 68Ga-DOTATOC PET/CT. Scans with SPECT/CT detected 19 lesions, all of which were also detected on PET/CT. Moreover, 16 additional lesions were detected on PET/CT (6 in the liver, 9 in the pancreas and 1 in the spleen). PET/CT exhibited a significantly higher sensitivity than SPECT/CT (100 % vs. 54 %, P < 0.001). TNR was significantly higher on PET/CT than on SPECT/CT (99.9 ± 84.3 vs. 71.1 ± 114.9, P < 0.001) in spite of a significant correlation (r = 0.692, P = 0.01).ConclusionGa-DOTATOC PET/CT has a higher diagnostic sensitivity than 111In-pentetreotide scans with SPECT/CT. The TNR on PET/CT is higher than that of SPECT/CT, which also suggests the higher sensitivity of PET/CT. 111In-pentetreotide SPECT/CT should be used carefully if it is used instead of 68Ga-DOTATOC PET/CT.
    16 schema:genre article
    17 schema:isAccessibleForFree true
    18 schema:isPartOf N5e2e5971d81243cdbeac57758ba691e9
    19 N8ac130307f52423aa3e29c3d4a73b0b5
    20 sg:journal.1016285
    21 schema:keywords CT
    22 MethodsThirteen patients
    23 PET
    24 PET/CT
    25 SPECT/CT
    26 TNR
    27 additional lesions
    28 advantages
    29 comparison
    30 correlation
    31 count
    32 detectability
    33 diagnostic sensitivity
    34 high diagnostic sensitivity
    35 high image quality
    36 high sensitivity
    37 image quality
    38 imaging
    39 index
    40 lesion detectability
    41 lesions
    42 location
    43 location of lesions
    44 lung
    45 lung ratio
    46 neuroendocrine tumors
    47 normal lung ratios
    48 number
    49 patients
    50 preliminary report
    51 quality
    52 quantitative index
    53 ratio
    54 receptors
    55 report
    56 scans
    57 sensitivity
    58 significant correlation
    59 somatostatin receptors
    60 spite
    61 study
    62 target
    63 technique
    64 treatment
    65 tumors
    66 uptake
    67 uptake counts
    68 schema:name Comparison of Diagnostic Sensitivity and Quantitative Indices Between 68Ga-DOTATOC PET/CT and 111In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report
    69 schema:pagination 284-290
    70 schema:productId N0052ac50f59f44199bf872d4635cd44b
    71 N07ff41c8ecf5413dbbacb1a373dcfa9a
    72 Nf9812cd926f24b239e001f4aa701b238
    73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034059814
    74 https://doi.org/10.1007/s13139-015-0356-y
    75 schema:sdDatePublished 2022-10-01T06:40
    76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    77 schema:sdPublisher N7d44874f44d54d768c12c01ab351c5a6
    78 schema:url https://doi.org/10.1007/s13139-015-0356-y
    79 sgo:license sg:explorer/license/
    80 sgo:sdDataset articles
    81 rdf:type schema:ScholarlyArticle
    82 N0052ac50f59f44199bf872d4635cd44b schema:name dimensions_id
    83 schema:value pub.1034059814
    84 rdf:type schema:PropertyValue
    85 N07ff41c8ecf5413dbbacb1a373dcfa9a schema:name doi
    86 schema:value 10.1007/s13139-015-0356-y
    87 rdf:type schema:PropertyValue
    88 N0d0d081490c448a6bcaa1dfcf0a0009b rdf:first sg:person.0751347234.39
    89 rdf:rest Nb0cdc39254aa4749b47bbd6e1f5a3ab0
    90 N1d7de12fc0a24ea5a29e9c8a9f5ea4c0 rdf:first sg:person.01343511335.32
    91 rdf:rest N855d29ab2fe44a1dbf9ccc6d0ae67c77
    92 N5e2e5971d81243cdbeac57758ba691e9 schema:issueNumber 4
    93 rdf:type schema:PublicationIssue
    94 N7d44874f44d54d768c12c01ab351c5a6 schema:name Springer Nature - SN SciGraph project
    95 rdf:type schema:Organization
    96 N855d29ab2fe44a1dbf9ccc6d0ae67c77 rdf:first sg:person.01226703142.42
    97 rdf:rest Nef9c8bd143874ff8b6776dc28ad26ab7
    98 N8ac130307f52423aa3e29c3d4a73b0b5 schema:volumeNumber 49
    99 rdf:type schema:PublicationVolume
    100 Na018014cb4e34cd39d255cff55323718 rdf:first sg:person.01216340016.54
    101 rdf:rest N1d7de12fc0a24ea5a29e9c8a9f5ea4c0
    102 Na58c721076d14535ab96dfa26d3ac446 rdf:first sg:person.01333472502.31
    103 rdf:rest Ndccaf6394bff4cb19f0bf39c612424f1
    104 Nb0cdc39254aa4749b47bbd6e1f5a3ab0 rdf:first sg:person.0761746266.86
    105 rdf:rest rdf:nil
    106 Ndccaf6394bff4cb19f0bf39c612424f1 rdf:first sg:person.015617314175.88
    107 rdf:rest N0d0d081490c448a6bcaa1dfcf0a0009b
    108 Ne0a9d71a3bfd49e093a9b3f43ffdb65f rdf:first sg:person.0617241524.44
    109 rdf:rest Na58c721076d14535ab96dfa26d3ac446
    110 Nef9c8bd143874ff8b6776dc28ad26ab7 rdf:first sg:person.0706114440.07
    111 rdf:rest Ne0a9d71a3bfd49e093a9b3f43ffdb65f
    112 Nf9812cd926f24b239e001f4aa701b238 schema:name pubmed_id
    113 schema:value 26550047
    114 rdf:type schema:PropertyValue
    115 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    116 schema:name Medical and Health Sciences
    117 rdf:type schema:DefinedTerm
    118 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    119 schema:name Clinical Sciences
    120 rdf:type schema:DefinedTerm
    121 sg:journal.1016285 schema:issn 1869-3474
    122 1869-3482
    123 schema:name Nuclear Medicine and Molecular Imaging
    124 schema:publisher Springer Nature
    125 rdf:type schema:Periodical
    126 sg:person.01216340016.54 schema:affiliation grid-institutes:grid.31501.36
    127 schema:familyName Lee
    128 schema:givenName Inki
    129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216340016.54
    130 rdf:type schema:Person
    131 sg:person.01226703142.42 schema:affiliation grid-institutes:grid.31501.36
    132 schema:familyName Lee
    133 schema:givenName Soo Jin
    134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226703142.42
    135 rdf:type schema:Person
    136 sg:person.01333472502.31 schema:affiliation grid-institutes:grid.31501.36
    137 schema:familyName Cheon
    138 schema:givenName Gi Jeong
    139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31
    140 rdf:type schema:Person
    141 sg:person.01343511335.32 schema:affiliation grid-institutes:grid.31501.36
    142 schema:familyName Paeng
    143 schema:givenName Jin Chul
    144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343511335.32
    145 rdf:type schema:Person
    146 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.31501.36
    147 schema:familyName Lee
    148 schema:givenName Dong Soo
    149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
    150 rdf:type schema:Person
    151 sg:person.0617241524.44 schema:affiliation grid-institutes:grid.31501.36
    152 schema:familyName Jang
    153 schema:givenName Jin-Young
    154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617241524.44
    155 rdf:type schema:Person
    156 sg:person.0706114440.07 schema:affiliation grid-institutes:grid.31501.36
    157 schema:familyName Shin
    158 schema:givenName Chan Soo
    159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706114440.07
    160 rdf:type schema:Person
    161 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
    162 schema:familyName Chung
    163 schema:givenName June-Key
    164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
    165 rdf:type schema:Person
    166 sg:person.0761746266.86 schema:affiliation grid-institutes:grid.31501.36
    167 schema:familyName Kang
    168 schema:givenName Keon Wook
    169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86
    170 rdf:type schema:Person
    171 sg:pub.10.1007/bf03006672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003746639
    172 https://doi.org/10.1007/bf03006672
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1007/s00259-007-0450-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004095362
    175 https://doi.org/10.1007/s00259-007-0450-1
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1007/s00259-011-1935-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006918703
    178 https://doi.org/10.1007/s00259-011-1935-5
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1007/s002590050034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036382831
    181 https://doi.org/10.1007/s002590050034
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.1007/s00261-012-9925-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1018718191
    184 https://doi.org/10.1007/s00261-012-9925-z
    185 rdf:type schema:CreativeWork
    186 sg:pub.10.1007/s11307-014-0795-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029679413
    187 https://doi.org/10.1007/s11307-014-0795-3
    188 rdf:type schema:CreativeWork
    189 sg:pub.10.1007/s12020-012-9631-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017361379
    190 https://doi.org/10.1007/s12020-012-9631-1
    191 rdf:type schema:CreativeWork
    192 sg:pub.10.1007/s12149-014-0900-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043318385
    193 https://doi.org/10.1007/s12149-014-0900-3
    194 rdf:type schema:CreativeWork
    195 sg:pub.10.1007/s13139-013-0258-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000221223
    196 https://doi.org/10.1007/s13139-013-0258-9
    197 rdf:type schema:CreativeWork
    198 grid-institutes:grid.31501.36 schema:alternateName Cancer Research Institute, Seoul National University, Seoul, Korea
    199 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
    200 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Gyeonggi-Do, Korea
    201 Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea
    202 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
    203 schema:name Cancer Research Institute, Seoul National University, Seoul, Korea
    204 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
    205 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Gyeonggi-Do, Korea
    206 Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea
    207 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
    208 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...